Page 3 - Nirvi Ashar News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Nirvi ashar. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Nirvi Ashar Today - Breaking & Trending Today

Early-bird results show tepid India Inc profits in Q4 season

Disappointing growth by IT companies drags down corporate performance in the fourth quarter while consumer and auto sectors maintain sustained momentum, shows a Moneycontrol analysis of results announced by 180 companies so far. ....

India General , Nirvi Ashar , Maruti Suzuki , Anmol Das , Tata Consultancy Services , Embassy Construction , Head Of Research At Teji Mandi , Hindustan Unilever Ltd , Teji Mandi , Tech Mahindra , Markets News , Equity Markets , March Quarter Earnings ,

TCS, Infosys, Wipro & Tech Mahindra slip up to 30% in a year; time to look for mid-cap IT stocks?

Shares of Infosys and TCS have cracked 22.2 per cent and 11.30 per cent in the last 12 months till April 18, 2023. On the other hand, the BSE Sensex gained 4.5 per cent during the same period. Other large-cap IT majors including Wipro, HCL Technologies and Tech Mahindra have also declined 32 per cent, 4 per cent and 24 per cent, respectively, since April last year.

....

United States , Nirvi Ashar , Shrey Jain , Nucleus Software , Motilal Oswal Financial Services , Sonata Software , Accelya Solutions India , Tata Consultancy Services , North America , Tech Mahindra , Cigniti Technologies , Nucleus Software Exports , Fundamental Analyst , Religare Broking , Pcs Shares , Wipro Shares , Tech Mahindra Shares , It Stocks , Market Cap , Bse Sensex ,

Budget 2023: 7 experts list what the auto sector expects from this year's budget

Most analysts don t see major announcements in the space, however, they expect some PLI-like incentives, some relief in GST (especially for electric vehicles), and further smoothening in the manufacturing process. ....

Nirvi Ashar , Saji John , Aditya Welekar , Vinit Bolinjkar , Aniket Mhatre , Head Of Research , Institutional Research Analyst , Geojit Financial Services , Ashok Leyland , Senior Research Analyst , Religare Broking , Ram Kalyan , Faster Adoption , Electric Vehicles , Fund Manager , Bright Horizons , Advanced Chemistry Cell , Axis Securities , Timeline Extension , Hero Motors , How Indian , View Full , Stock Markets , Auto Sect , Auto Industry , Budget 2023 ,

Headed for a rise or fall? Here's where 7 experts see the auto space going in next 6 months

Going ahead most analysts have mixed views on the space. While the pent-up demand is fading and the sector is facing rising interest rates and further price hikes expected the export; However, margin improvement is expected due to a decrease in commodity prices and price hikes. ....

Maruti Suzuki , Nirvi Ashar , Saji John , Aditya Welekar , Vinit Bolinjkar , Aniket Mhatre , Uno Minda , Head Of Research , Ashok Leyland , Motor Co , Minda Corp , Bajaj Auto , Geojit Financial Services , Eicher Motors , Institutional Research Analyst , Senior Research Analyst , Fund Manager , Bright Horizons , Religare Broking , Ram Kalyan , Hero Motocorp , Jamna Auto , Endurance Tech , Sundram Fasteners , Axis Securities , Auto Expo ,

Windlas Biotech IPO: Windlas Biotech offers its shares at 64x PE. Should you subscribe?

NEW DELHI: Analysts tracking primary issues believe one can subscribe to the initial public offering of Windlas Biotech, a Contract Development Manufacturing Organisation (CDMO), for the long term. The issue opens for subscription today.
The Dehradun-based firm will raise Rs 165 crore through issuance of fresh equity shares, while the promoters and existing shareholders will offload 51,42,067 equity shares worth Rs 236 crore via an offer-for-sale (OFS). The price band for the issue is fixed at Rs 448-460 per share.
“Windlas is focusing on formulation CDMO, and there is no peer company focusing solely on the CDMO model. Considering its return ratios and profitability, the issue seems to be fully priced. But factoring the growth drivers of the CDMO sector and opportunities available for the company, we assign a ‘subscribe for long term’ rating on the issue,” said Rajnath Yadav of Choice Broking. ....

Emcure Pharma , Rajnath Yadav , Nirvi Ashar , Contract Development Manufacturing Organisation , Windlas Biotech , Dehradun Plant , Sanofi India , Cadila Healthcare , Marwadi Shares , Angel Broking , ராஜ்நாத் யாதவ் , நிர்வி ஆஷர் , ஒப்பந்த வளர்ச்சி உற்பத்தி ஆர்கநைஸேஶந் , விண்ட்லாஸ் பயோடெக் , டெஹ்ராடூன் ஆலை , சனோஃபி இந்தியா , காடிலா சுகாதாரம் , மார்வாடி பங்குகள் , தேவதை தரகு ,